✦ LIBER ✦

Comparison of cisplatin plus pemetrexed and cisplatin plus gemcitabine for the treatment of malignant pleural mesothelioma in Japanese patients

✍ Scribed by Shukuya, Takehito; Takahashi, Toshiaki; Imai, Hisao; Tokito, Takaaki; Ono, Akira; Akamatsu, Hiroaki; Taira, Tetsuhiko; Kenmotsu, Hirotsugu; Naito, Tateaki; Murakami, Haruyasu; Endo, Masahiro; Yamamoto, Nobuyuki

Book ID: 125476964
Publisher: Elsevier
Year: 2014
Tongue: English
Weight: 398 KB
Volume: 52
Category: Article
ISSN: 2212-5345
DOI: 10.1016/j.resinv.2013.07.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CN2 VALUE-FOR-MONEY OF PEMETREXED PLUS C

CN2 VALUE-FOR-MONEY OF PEMETREXED PLUS CISPLATIN VERSUS CISPLATIN ALONE IN THE TREATMENT OF MALIGNANT PLEURAL MESOTHELIOMA

✍ P Davey; A Cordony; N Rajan; B Arora; N Pavlakis 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

Cost-Effectiveness of Pemetrexed Plus Ci

Cost-Effectiveness of Pemetrexed Plus Cisplatin: Malignant Pleural Mesothelioma Treatment in UK Clinical Practice

✍ Anna Cordony; Corinne Le Reun; Antje Smala; James T. Symanowski; Jessamy Watkins 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB

PCN1 ECONOMIC IMPACT OF ADOPTING PEMETRE

PCN1 ECONOMIC IMPACT OF ADOPTING PEMETREXED PLUS CISPLATIN FOR MALIGNANT PLEURAL MESOTHELIOMA INTO SCOTTISH CLINICAL PRACTICE

✍ M Chetty; A Cordony; P Davey; K Karampela; C Le Reun; M Watt 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

1139 POSTER Economic impact of adopting

1139 POSTER Economic impact of adopting pemetrexed plus cisplatin for malignant pleural mesothelioma into scottish clinical practice

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 415 KB

P-435 Long-term survival update from the

P-435 Long-term survival update from the randomized phase III study of pemetrexed plus cisplatin vs cisplatin in patients with malignant pleural mesothelioma (MPM)

✍ Vogelzang, N.; Symanowski, J.; Rusthoven, J.; Manegold, C.; Boyer, M.; Nguyen, B 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 323 KB

O-56 Symptom and quality of life advanta

O-56 Symptom and quality of life advantages for pemetrexed + cisplatin versus cisplatin in treatment of malignant pleural mesothelioma

✍ Boyer, M.J.; Jassem, J.; Liepa, A.M.; Symanowski, J.T.; Kaukel, E.; Denham, C.A. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 183 KB